← Leaderboards
Santosh Aryal
Kansas State University
$867,940
Attributed
$867,940
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $441K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$867,940 · 2
By mechanism
R15$867,940 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Clinical Translation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Lynn Briscoe · Leidos Biomedical Research, Inc.$130,241,827
- Leonard Freedmand · Leidos Biomedical Research, Inc.$95,252,769
- Bambra Strokes · Ppd Development Lp$65,000,267
- Klaus Romero · Critical Path Institute$56,862,776
- Prasant Mohapatra · University Of California At Davis$51,504,377
Research focus
Clinical TranslationDoxorubicinCell Adhesion MoleculesCell Surface ReceptorsDisseminated Malignant NeoplasmDistantCareerCd8b1 GeneAntigen-Presenting CellsCellsDesignBiomaterial CompatibilityBiomedical ResearchBiochemicalBiodistributionBreastBreast Cancer CellCd4 Positive T LymphocytesBiologicalCancer CellBiological MarkersCancerousCancer TherapyDrug Delivery Systems
Grant awards (3)
Engineering Natural Killer Cell Derived Extracellular Vesicular Nanodrug for Tumor Targeted Bioimaging and Therapy$441,000
R15 · FY2025 · EB · contact PI
Re-engineering Tumor Cell-Derived Extracellular Vesicles with Exogenous Tags for Downstream Analysis$405,400
R15 · FY2020 · EB · contact PI
Re-engineering Tumor Cell-Derived Extracellular Vesicles with Exogenous Tags for Downstream Analysis$21,540
R15 · FY2020 · EB · contact PI